Showing results (61-70 of 109) with videos related to
Sort By:
Pageof 11
Epilepsia Open|September 20, 2021
Drug-resistant epilepsy: Drug target hypothesis and beyond the receptorsDaniel Fonseca-Barriendos, Christian Lizette Frías-Soria, Daniel Pérez-Pérez, et al.Neurochemistry International|September 15, 2018
Neuroprotective effects of levetiracetam, both alone and combined with propylparaben, in the long-term consequences induced by lithium-pilocarpine status epilepticusCésar Emmanuel Santana-Gómez, María Guadalupe Valle-Dorado, Ana Esmeralda Domínguez-Valentín, et al.Current Pharmaceutical Design|March 28, 2013
P-glycoprotein contributes to cell membrane depolarization of hippocampus and neocortex in a model of repetitive seizures induced by pentylenetetrazole in ratsJerónimo A Auzmendi, Sandra Orozco-Suárez, Ivette Bañuelos-Cabrera, et al.Frontiers in Bioscience (Elite Edition)|June 5, 2014
Pharmacoresistant epilepsy and nanotechnologyArgelia Rosillo-de la Torre, Gabriel Luna-Bárcenas, Sandra Orozco-Suárez, et al.Frontiers in Pharmacology|September 8, 2025
Analysis of six CYP450 genetic variants regarding the response to cannabidiol combined with anticonvulsant medication in mexican patients with drug-resistant epilepsyIris A Feria-Romero, Luisa Rocha, Araceli Reyes-Cuayahuitl, et al.Journal of Neurochemistry|October 21, 2014
Differential effects of exercise on brain opioid receptor binding and activation in ratsRicardo Mario Arida, Sérgio Gomes da Silva, Alexandre Aparecido de Almeida, et al.Epilepsy Research|October 27, 2018
Overexpression of inflammatory-related and nitric oxide synthase genes in olfactory bulbs from frontal lobe epilepsy patientsOctavio Fabián Mercado-Gómez, Laura Córdova-Dávalos, Delfina García-Betanzo, et al.Neurotoxicology|February 9, 2017
Propylparaben applied after pilocarpine-induced status epilepticus modifies hippocampal excitability and glutamate release in ratsCésar Emmanuel Santana-Gómez, Sandra Adela Orozco-Suárez, Alan Talevi, et al.Frontiers in Behavioral Neuroscience|May 22, 2020
Endocannabinoid System and Cannabinoid 1 Receptors in Patients With Pharmacoresistant Temporal Lobe Epilepsy and Comorbid Mood DisordersLuisa Rocha, Resat Cinar, Rosalinda Guevara-Guzmán, et al.Antioxidants (Basel, Switzerland)|June 26, 2025
Subchronic Intranasal Administration of NeuroEPO Reduces Long-Term Consequences of Severe Traumatic Brain Injury in Male RatsFélix Iván López-Preza, Maria de Los Angeles Nuñez-Lumbreras, Iliana Sosa-Testé, et al.Pageof 11